Mucus
Pricing Report NDC 63868-389-20

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Mucus (NDC 63868-389-20) is $0.30143 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 18, 2020.

As a provided by Chain Drug Marketing Association Inc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.30143
Per EA

Effective Date
Nov 18, 2020
Billable Units
1 EA
Estimated Package Price
$0.30
Data Status
As of Dec 02, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.30143 to $0.52410 per EA. Over this 1 year and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3014 - $0.5241
Market Volatility
73.87% Variance
Latest Trend
4.45%
Date Unit Price Unit Source Method Rate
Nov 18, 2020 $0.30143 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $0.31547 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $0.40305 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2020 $0.33321 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $0.34433 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $0.33696 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2020 $0.41005 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.31712 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.35095 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.40515 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.31196 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.44879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2019 $0.31688 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.52410 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2019 $0.34976 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $0.48987 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2019 $0.37278 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026